You are here: Industry Insights > Q1

News List

Cadila Healthcare’s net profit rises 29 per cent in Q1 expresspharma
August 13, 2021
Cadila Healthcare 10th reported a 29.33 per cent rise in its consolidated net profit to Rs 587.2 crores for the quarter ended on 30th June, 2021, mainly on account of robust sales in the Indian market.
AstraZeneca India’s Q1 net profit declines 45 per cent expresspharma
August 11, 2021
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period a year ago.
Cipla Q1 net profit rises 25 per cent to Rs 709.92 crores expresspharma
August 09, 2021
The company had posted a net profit of Rs 566.04 crores in the corresponding period of the previous fiscal, Cipla said in a filing to BSE.
Alembic Pharma Q1 net profit declines to Rs 165 cr expresspharma
July 29, 2021
The company had posted a net profit of Rs 301.46 crores for the corresponding period of the previous fiscal, Alembic Pharmaceuticals said in a regulatory filing.
Novartis Releases Q1 Results, Updates COVID-19 Global Response americanpharmaceuticalreview
May 04, 2020
Novartis reported net income increased 34% to $3.55 billion in Q1 2020. Sales increased 13% to $12.3 billion. Key growth drivers included Entresto, Zolgensma, Kisqali, and Piqray.
Sun Pharma reports Q1FY20 results expresspharma
August 15, 2019
Sun Pharmaceutical Industries has announced its Q1FY20 results, reporting a surge of 16 per sent in its gross sales which stood at Rs.8,259 crores. The net profit also witnessed a hike of 31 per cent at Rs 1387 crores.
Wockhardt Q1 net loss narrows to Rs 45 crore expresspharma
August 15, 2019
Wockhardt has reported narrowing of its consolidated net loss to Rs 44.98 crore for the quarter ended June 30, 2019. The company had posted a net loss of Rs 89.18 crore in the same period a year ago.
Lupin Q1 net profit up 49 pc to Rs 303.05 expresspharma
August 08, 2019
Lupin has reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.
Syngene announces Q1 FY20 results expresspharma
July 26, 2019
Syngene International has announced its Q1 FY20 results, wherein the company posted quarterly revenue of Rs 441 crores, an increase of four per cent from the corresponding quarter last year.
GSK Pharmaceuticals’ revenue grows at seven per cent in Q1 expresspharma
July 25, 2019
GlaxoSmithKline Pharmaceuticals has declared its financial results for the quarter ended 30th June 2019. Revenue for the quarter came in at Rs 788 crores, an increase of seven per cent over the same period last year.

Previous page 1 2 Next page